Differential serum protein markers and the clinical severity of asthma
Open Access
- 1 April 2014
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. 7, 67-75
Abstract
Background: Asthma is a heterogeneous disease characterized by different clinical phenotypes and the involvement of multiple inflammatory pathways. During airway inflammation, many cytokines and chemokines are released and some are detectable in the sera. Objective: Serum chemokines and cytokines, involved in airway inflammation in asthma patients, were investigated. Methods: A total of 191 asthma patients were classified by hierarchical cluster analysis, including the following parameters: forced expiratory volume in 1 second (FEV1), eosinophil cationic protein (ECP) serum levels, blood eosinophils, Junipers asthma symptom score, and the change in FEV1, ECP serum levels, and blood eosinophils after 3 weeks of asthma therapy. Serum proteins were measured by multiplex analysis. Receiver operating characteristic (ROC) curves were used to evaluate the validity of serum proteins for discriminating between asthma clusters. Results: Classification of asthma patients identified one cluster with high ECP serum levels, increased blood eosinophils, low FEV1 values, and good FEV1 improvement in response to asthma therapy (n=60) and one cluster with low ECP serum levels, low numbers of blood eosinophils, higher FEV1 values, and no FEV1 improvement in response to asthma therapy (n=131). Serum interleukin (IL)-8, eotaxin, vascular endothelial growth factor (VEGF), cutaneous T-cell-attracting chemokine (CTACK), growth-related oncogene (GRO)-α, and hepatocyte growth factor (HGF) were significantly different between the two clusters of asthma patients. ROC analysis for serum proteins calculated a sensitivity of 55.9% and specificity of 75.8% for discriminating between them. Conclusion: Serum cytokine and chemokine levels might be predictors for the severity of asthmatic inflammation, asthma control, and response to therapy, and therefore might be useful for treatment optimization.Keywords
This publication has 27 references indexed in Scilit:
- Serum cytokines markers in toluene diisocyanate-induced asthmaRespiratory Medicine, 2011
- Asthma endotypes: A new approach to classification of disease entities within the asthma syndromeJournal of Allergy and Clinical Immunology, 2011
- The many paths to asthma: phenotype shaped by innate and adaptive immunityNature Immunology, 2010
- Role of Treg in immune regulation of allergic diseasesEuropean Journal of Immunology, 2010
- IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitisJournal of Allergy and Clinical Immunology, 2010
- Mechanisms and treatment of allergic disease in the big picture of regulatory T cellsJournal of Allergy and Clinical Immunology, 2009
- Interleukin-17A modulates human airway epithelial responses to human rhinovirus infectionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Interleukin-17 Orchestrates the Granulocyte Influx into Airways after Allergen Inhalation in a Mouse Model of Allergic AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Activated T Cells and Cytokines in Bronchoalveolar Lavages from Patients with Various Lung Diseases Associated with EosinophiliaAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992